James Whittenburg, CEO of HealthTronics, said: “HealthTronics brings deep and capable resources to bear in restructuring the existing UroPath model to fully address the regulatory environment while preserving, to the greatest extent possible, the tangible patient and quality of care benefits.
“Our existing laboratory, ClariPath, adds significant flexibility and efficiencies as we refine the UroPath business model.”